MRK241101C90000
- 14.55
- 0.000.00%
Merck & Co Newsroom
Merck Tops Earnings Estimates but Lowers Full-Year Guidance
Halloween Market Falls, Scared of Meta and Microsoft CapEx | Live Stock
Bristol Myers Squibb Stock Rises, Merck Moves Lower. Here's Why.
Dow's 179-Point Fall Led By Losses For Microsoft, Merck Shares
Express News | Merck & Co CEO Says Co Expects to Continue to See a Decline in Gardasil Shipments Into China Into 2025 - Conf. Call
Today's Pre-Market Movers and Top Ratings | EL, META, MSFT, UBER and More
Express News | Merck Shares Reverse Course, Last Down 1.6% Premarket
HPV vaccine sales decline, merck lowers upper limit of full-year revenue guidance.
merck lowered the upper limit of its full-year sales guidance, as demand for its HPV vaccine in the china market declined for the second consecutive quarter.
Stock Futures Down as Investors Await Key Inflation Report, Parse Microsoft, Meta Results; Asia, Europe Down
Express News | Merck & Co Says Making Progress With Chinese Partner Zhifei to Increase Promotional Resources and Patient Education Efforts Around Gardasil
Express News | Merck & Co- in China, Shipped Less to Zhifei, Sees Q4 Shipments Will Be at Similar Level to Q3
Merck & Co Inc. Q3 Profit Falls
Merck's Q3 Earnings Beat Estimates but Company Lowers Guidance
Merck in Charts: KEYTRUDA Continues to Show an Upward Trend Past 3 Years, Rises ~17% in Q3
Earnings Flash (MRK) MERCK & CO. Reports Q3 Revenue $16.66B
Earnings Flash (MRK) MERCK & CO. Posts Q3 EPS $1.57
Express News | Merck Shares Rise 1.4% Premarket After Q3 Results Beat
Merck Tops Earnings Estimates on Strong Demand for Keytruda, New Drugs Even as HPV Vaccine Sales Fall
Merck Non-GAAP EPS of $1.57 In-line, Revenue of $16.7B Beats by $190M
Merck Posts 79c/Share 3Q Charge Related to Business Development Transactions >MRK